Article

Non-Coding RNAs and Innovative Therapeutic Strategies to Target the 5’UTR of SARS-CoV-2

2020-04-24

Abstract excerpt

After the increasing number of SARS-CoV-2 infections all over the world, researchers and clinicians are struggling to find a vaccine or innovative therapeutic strategies to treat this viral infection. The SARS-CoV infection that occurred in 2002, MERS and other more common infectious diseases such as HCV, led to the discovery of many RNA-based drugs. Among them, siRNAs and antisense LNAs have been demonstrated to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e4a68da3-44d3-5c4b-a19c-aed502de9c2f
DOI: 10.20944/preprints202004.0425.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Non-Coding RNAs and Innovative Therapeutic Strategies to Target the 5’UTR of SARS-CoV-2DOI 10.20944/preprints202004.0425.v1Read

Potential Use of Noncoding RNAs and Innovative Therapeutic Strategies to Target the 5’UTR of SARS-CoV-2Semantic proximity Read

Structural and Functional RNA Motifs of SARS-CoV-2 and Influenza A Virus as a Target of Viral InhibitorsSemantic proximity Read

Non-Coding RNAs and SARS-Related Coronaviruses.Semantic proximity Read

Unveiling the translational and therapeutic potential of small interfering RNA molecules in combating SARS-CoV-2: A reviewSemantic proximity Read

RNA interference as a promising treatment against SARS-CoV-2Semantic proximity Read

Inhibition of SARS-CoV-2 by Targeting Conserved Viral RNA Structures and SequencesSemantic proximity Read

The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A reviewSemantic proximity Read

In Silico and In Vitro Development of novel small interfering RNAs (siRNAs) to inhibit SARS-CoV-2Semantic proximity Read

Integrative analyses of SARS-CoV-2 genomes from different geographical locations reveal unique features potentially consequential to host-virus interaction, pathogenesis and clues for novel therapiesSemantic proximity Read

An in silico analysis of effective siRNAs against COVID‐19 by targeting the leader sequence of SARS‐CoV‐2Semantic proximity Read

Transcriptomics and RNA-Based Therapeutics as Potential Approaches to Manage SARS-CoV-2 InfectionSemantic proximity Read

Antisense oligonucleotide: A promising therapeutic option to beat COVID ‐19Semantic proximity Read